Company Performance Metrics
EAAT uses bioprinting technology to produce sustainable fish products for human consumption. EAAT has acquired the exclusive rights to use and modify the intellectual property of the global leader in live cell printing for the manufacture and sale of bioprinted fish and meat. Initially, with this technology, and our expertise and experience, we
will sustainably produce and sell lab-grown, non-GMO, edible and marketable fish protein. EAAT will ultimately manufacture consumable fish and meat products with minimal waste, without contaminants and without depleting the worlds’ natural resources or destroying its environment.
EAAT’S proprietary bioprinting technology is currently the most precise on the market. The design and features of EAAT's bioprinter provide the flexibility necessary to manufacture our end product successfully and achieve our scaling timeline. Today, there are a few different 3D cell printers commercially available responding to a rising demand for live cell printing, for customizable live cell arrays, tissue bio-fabrication/bioprinting research and other applications. EAAT’s proprietary technology offers the only 3D cell printer on the market with 95% live cell viability, whereas other bioprinters typically print at less than 50% viability. It can also print up to 16 channels at once, providing the ability to print all cell lines, media and other materials at once. EAAT’s ability to control all aspects of production through the vertical integration of its supply chain, coupled with the ability to print cells at a faster rate and with greater viability, and its already established distribution network, provides EAAT with a significant advantage over its potential competitors.